Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Daniel Cowell


Mr. Daniel Cowell is a Co-Founder and serves as the Chief Executive Officer and Board Member at Psyomics. He is a Board Member of Sentinal Oncology. He served as Chief Operating Officer at Horizon Discovery. He co-founded Pharmorphix, a specialist CRO in the area of solid form, which grew market share rapidly and was subsequently acquired by Sigma Aldrich in 2006. Following the sale of Pharmorphix he founded Hypoxium, a client focused CRO providing pre-clinical oncology research which grew its revenue at over 75% each year. He was appointed COO of Horizon Discovery following Hypoxium's acquisition in 2010. He holds a BS in Chemistry from University of Kent.

Primary Investor Type
Angel (individual)

Daniel Cowell Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000000 10-Nov-2014 0000 00000 00.000 Business/Productivity Software Generating Revenue 000000 000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Daniel Cowell’s full profile, request a free trial.

Daniel Cowell Team (1)

Name Title Deals Funds Boards Office Contact
Daniel Cowell Angel Investor 0 0 London, United Kingdom